Institutional investors purchased a net $6.0 million shares of CYTR during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 8.16% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREATIVE PLANNING, INC. Bought 8.00 shares of CytRx Corp
MEEDER ASSET MANAGEMENT, INC. Sold 517.00 shares of CytRx Corp